Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,2 USD | +1,59 % | +0,95 % | -0,62 % |
Resumen de negocios
Número de empleados: 40
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -73,93 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -73,93 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01/04/14 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 01/01/19 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 28/06/23 |
Manoj Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 08/02/23 |
Jason Tardio
COO | Chief Operating Officer | 47 | 18/11/19 |
Julia Tsai
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/21 |
Thomas Perone
CMP | Compliance Officer | 59 | 21/03/19 |
Toshiya Nishi
PRN | Corporate Officer/Principal | - | 08/02/23 |
Megan Alexander
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01/09/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 14/06/17 |
Bart Friedman
BRD | Director/Board Member | 79 | 23/11/15 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01/04/14 |
Karen Bernstein
BRD | Director/Board Member | 71 | 30/09/15 |
Robert Poole
BRD | Director/Board Member | 67 | 09/07/21 |
Kevin Fitzgerald
BRD | Director/Board Member | 56 | 06/10/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 70 709 857 | 59 403 066 ( 84,01 %) | 0 | 84,01 % |
Acción B | 0 | 1 250 | 0 | 0 |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-0,62 % | 226 M | |
-0,49 % | 105 mil M | |
+3,31 % | 97,5 mil M | |
+3,17 % | 22,19 mil M | |
-16,16 % | 21,33 mil M | |
-7,05 % | 18,68 mil M | |
-41,41 % | 16,6 mil M | |
-22,87 % | 14,52 mil M | |
+6,32 % | 14,09 mil M | |
+21,46 % | 10,99 mil M |
- Bolsa de valores
- Acciones
- Acción OVID
- Empresa Ovid Therapeutics Inc.